| Financial Year |
March 31 2023 |
| Monetary Funds |
37,072,427,682.60 |
| Held-for-trading Financial Assets |
4,926,291,576.34 |
| Notes Receivable |
2,348,975,202.70 |
| Accounts Receivable |
5,119,144,709.95 |
| Advances to Suppliers |
1,527,972,380.62 |
| Other Receivables |
654,427,997.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
14,211,389,248.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,258,843,947.79 |
| Total Current Assets |
87,375,874,859.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
386,574,662.03 |
| Investment Properties |
106,555,439.28 |
| Fixed Assetes |
55,105,535,404.11 |
| Under-construction Projects |
7,136,773,832.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
6,915,633.85 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,153,451,941.38 |
| R&D expenses |
-- |
| Goodwill |
603,006,493.02 |
| Long-Term Deferred and Prepaid Expenses |
367,460,522.01 |
| Deferred Income Tax Assets |
1,566,128,488.01 |
| Other Non-Current Assets |
2,452,753,531.89 |
| Sub-Total of Non-Current Assets |
75,154,867,233.57 |
| Total Assets |
162,530,742,093.50 |
| Short-Term Loans |
195,030,038.85 |
| Trading Financial liabilities |
47,769,167.25 |
| Notes Payable |
8,663,108,612.06 |
| Accounts Payable |
11,682,444,664.31 |
| Accounts Received In Advance |
62,777,876.62 |
| Employee Compensation Payable |
1,746,078,197.26 |
| Taxes Payable |
3,202,289,746.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,282,317,005.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,553,943,381.65 |
| Other Current Liabilities |
879,463,050.83 |
| Sub-Total of Current Liabilities |
35,614,132,556.28 |
| Long-term Loans |
22,179,346,979.54 |
| Bonds Payable |
10,377,552,482.93 |
| Long-Term Accounts Payable |
956,487,044.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
231,124,139.43 |
| Deferred Income Tax Liabilities |
1,228,043,580.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,756,057,061.24 |
| Total Liabilities |
78,370,189,617.52 |
| Paid-In Capital(Or Share Stock) |
4,501,955,828.00 |
| Capital Surplus |
16,127,101,863.00 |
| Surplus Reserve |
2,407,355,585.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
44,455,141,050.11 |
| Minority Stockholder's Interest |
14,776,317,820.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
69,384,234,655.02 |
| Owner's Equity（Stockholder's Equity） |
84,160,552,475.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
162,530,742,093.50 |
